Oncology & Cancer

Patients prefer stool test to colonoscopy

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study.

Oncology & Cancer

Final advice: Panel against routine prostate test

Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.

Oncology & Cancer

Should you get tested for the 'Breast cancer genes'?

(HealthDay)—Women who have specific mutations in genes known as BRCA are at increased risk for breast and ovarian cancers. Now, an influential expert panel reaffirms that certain women should be screened for the genes.

Oncology & Cancer

U.S. panel rejects ovarian cancer screening

(HealthDay) -- A leading U.S. government panel has renewed its 2004 recommendation that women at average risk for ovarian cancer not get screened for the disease.

Oncology & Cancer

Expert panel suggests PSA test may benefit some men

(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.

page 5 from 9